Exploring Obesity and Cancer: An Interview with Molecular Biologist Condi Carmack
In this episode of The Downsized, hosts Christopher and Laraine Durham introduce molecular biologist Condi Carmack, who shares his weight loss journey using GLP-1 medication Terzapatide. Condi, having a background in molecular immunology and cancer genetics, discusses his personal experience with the medication, its effects on his blood pressure, and weight management. The conversation extends to broader topics, including the connection between obesity and cancer, current research on incretins, and compounded vs. name-brand medications. Moreover, Condi talks about his website, CancerObesityConnection.org, where he provides resources and information on the link between obesity and cancer. The discussion ends with Condi sharing insights and advice for those considering GLP-1 medications.
00:00 Welcome to The Downsized
00:56 Meet Condi Carmack: Molecular Biologist
03:12 Condi's Weight Loss Journey with Terzapatide
07:10 The Science Behind Compounded Terzapatide
15:50 Cancer and Obesity: The Connection
24:45 Future of Cancer Treatment and Obesity
34:54 Condi's Advice and Final Thoughts
37:27 Closing Remarks and Subscribe